Skip to main content
Clinical Trials/TCTR20220904002
TCTR20220904002
Active, not recruiting
Phase 4

Effects of dietary supplementation containing lutein, zeaxanthin, and omega-3 polyunsaturated fatty on the serum carotenoids and fatty acids concentrations, macular pigment and visual function in people with long-term computer display light exposure

BYHEALTH Institute of Nutrition & Health0 sites600 target enrollmentSeptember 4, 2022

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Serum carotenoids and fatty acids concentrations, macular pigment and visual function in people with long-term computer display light exposure
Sponsor
BYHEALTH Institute of Nutrition & Health
Enrollment
600
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 4, 2022
End Date
December 31, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
BYHEALTH Institute of Nutrition & Health

Eligibility Criteria

Inclusion Criteria

  • 1\) Individuals aged between18 and 45 years who has a screen time of more than 8 h/day within two years
  • 2\) were able and willing to consent to both the qualification and the randomization/follow\-up phases of the study
  • 3\) were likely, willing and able to undergo examinations for at least three times
  • 4\) agreed to stop current use of supplements containing lutein, zeaxanthin, omega\-3 LCPUFAs (specifically DHA and EPA), beta\-carotene, other than those supplied by our study

Exclusion Criteria

  • 1\) A chronic requirement for any systemic or ocular medication administered for other diseases and known to be toxic to the retina or optic nerve
  • 2\) Previous daily supplementation with lutein and/or omega\-3 LCPUFAs within six months
  • 3\) History of ocular trauma or eye surgery
  • 4\) A chronic requirement for any systemic or ocular medication administered for other diseases and known to be toxic to the retina or optic nerve
  • 5\) Any condition that would make adherence or follow\-up difficult or unlikely

Outcomes

Primary Outcomes

Not specified

Similar Trials